Clinical Handbook Of Psychotropic Drugs24/E

Item Information
Item#: 9780889375932
Edition 24
Author Procyshyn / Bezchlibnyk-Butler
Publisher Login Brothers Canada
Cover SP
On Hand 3

Ric M. Procyshyn (Editor); Kalyna Z. Bezchlibnyk-Butler (Editor); J. Joel Jeffries (Editor)

Quick and comprehensive information on psychotropic drugs for adults.Accurate and up-to-dateComparison charts help decision-makingIcons and full colorAvailable in print and onlineDownloadable patient info sheetsThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiased, up-to-datePacked with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions?) for a quick overview of treatment optionsSuccinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drugPotential interactions and side effects summarized in comparison chartsWith instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seekClearly written patient information sheets available for download as printable PDF filesThis book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.New in this edition:Neuroscience-based nomenclature - added to product availability tablesAntidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also updates to SSRI use in pregnancy and antidepressant augmentation strategiesAntipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairmentMood stabilisers chapter sections on Lithium and Anticonvulsants have been extensively revisedNew formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta(lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection)